Logo
Login

Company Executives

$ Management Team

Dr. Wendell Wierenga

Independent Chairman of the Board

Age 77
Compensation $589.1K USD
Sex Male

Dr. R. Scott Struthers

President

Chief Executive Officer

Co-Founder

Director

Age 63
Compensation $10.53M USD
Sex Male

Mr. Tobin Schilke

Chief Financial Officer

Age 50
Compensation -
Sex Male

Dr. Stephen Betz

Co-Founder

Chief Scientific Officer

Age 59
Compensation $4.124M USD
Sex Male

Ms. Isabel Kalofonos

Chief Commercial Officer

Age 54
Compensation -
Sex Female

Mr. Jeff Knight

Chief Development and Operating Officer

Age 54
Compensation $4.123M USD
Sex Male

Board of Directors

From the proxy statement filed Apr 29, 2026
Directors
8
serving now
Independent
7 of 8
stated in the proxy
Average tenure
8.2 years
from year joined
CEO also chairs the board
No
Wendell Wierenga, Ph.D.
Director Age On board Independent Committees Other public boards 2025 pay Source
Caren Deardorf
61 2022
4 years
 Independent
Nominating and Corporate Governance Global Therapeutics Strategy and Access
None stated $485,467
Weston Nichols, Ph.D.
41 2018
8 years
 Independent None stated None stated $493,844
Stephanie S. Okey, M.S.
66 2019
7 years
 Independent None stated PTC Therapeutics $500,467
Camille Bedrosian, M.D.
73 2020
6 years
 Independent
Research and Development · Chair Nominating and Corporate Governance Global Therapeutics Strategy and Access
None stated $500,467
Wendell Wierenga, Ph.D.
Board chair
 78 2015
11 years
 Independent
Nominating and Corporate Governance · Chair Compensation Research and Development
Dermata Therapeutics, Inc. $528,617
R. Scott Struthers, Ph.D.
CEO
 64 2008
18 years
 Not independent None stated None stated Paid as CEO
Matthew K. Fust
61 2018
8 years
 Independent None stated Atara Biotherapeutics, Inc. $498,592
Rogério Vivaldi Coelho, M.D.
62 2022
4 years
 Independent None stated Viatris Inc. $507,342

Each director opens the passage of the proxy that names them. "Not stated" means the proxy does not say; it never means "no". Pay is the proxy's Director Compensation table; the CEO is paid as an executive.

Related-party transactions

No related-party transactions disclosed

The proxy filed Apr 29, 2026 describes a review policy but reports no transactions.

Read the policy in the proxy

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support
View Pricing Plans